Subgroup analysis of efficacy endpoints-potential relationship between objective response rate and co-mutation status
| Title | Subgroup analysis of efficacy endpoints-potential relationship between objective response rate and co-mutation status |
|---|---|
| Description | In the subgroup analysis, we evaluated the potential relationship between objective response rate (ORR) and co-mutation status. A superior response was seen in patients with KRAS G12C and PIK3CA co-mutation, while an inferior response was seen in patients with KRAS G12C and STK11 or KEAP1 co-mutations. |
| Organism | Homo sapiens |
| Data Type | Clinical Research data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA023276 |
| Release Date | 2024-01-30 |
| Submitter | Diandian Wang (diandian.wang@inventisbio.com) |
| Organization | InventisBio Co., Ltd |
| Submission Date | 2024-01-29 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX005764-02 | Co-mutation status from clinical information. | 1 | Clinical Research data | 170.2 KB | zip | 0 | Controlled |